Global and United States Neurogenetic Testing Market Report & Forecast 2022-2028

Table of Contents

1 Study Coverage

• 1.1 Neurogenetic Testing Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Neurogenetic Testing Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Neurogenetic Testing Market Size for the Year 2017-2028
  • 1.2.2 Global Neurogenetic Testing Market Size for the Year 2017-2028
• 1.3 Neurogenetic Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Neurogenetic Testing in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Neurogenetic Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Neurogenetic Testing Market Dynamics
  • 1.4.1 Neurogenetic Testing Industry Trends
  • 1.4.2 Neurogenetic Testing Market Drivers
  • 1.4.3 Neurogenetic Testing Market Challenges
  • 1.4.4 Neurogenetic Testing Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Neurogenetic Testing by Type

• 2.1 Neurogenetic Testing Market Segment by Type
  • 2.1.1 MRI
  • 2.1.2 Next Generation Sequencing
  • 2.1.3 Multiplex Ligation-dependent Probe Amplification (MLPA)
  • 2.1.4 Fragment Analysis PCR
• 2.2 Global Neurogenetic Testing Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Neurogenetic Testing Market Size by Type (2017-2028)
• 2.4 United States Neurogenetic Testing Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Neurogenetic Testing Market Size by Type (2017-2028)

3 Neurogenetic Testing by Application

• 3.1 Neurogenetic Testing Market Segment by Application
  • 3.1.1 Hospitals
  • 3.1.2 Specialty Clinics
  • 3.1.3 Research Institutes
  • 3.1.4 Diagnostics Laboratories
• 3.2 Global Neurogenetic Testing Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Neurogenetic Testing Market Size by Application (2017-2028)
• 3.4 United States Neurogenetic Testing Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Neurogenetic Testing Market Size by Application (2017-2028)

4 Global Neurogenetic Testing Competitor Landscape by Company

• 4.1 Global Neurogenetic Testing Market Size by Company
  • 4.1.1 Top Global Neurogenetic Testing Companies Ranked by Revenue (2021)
  • 4.1.2 Global Neurogenetic Testing Revenue by Player (2017-2022)
• 4.2 Global Neurogenetic Testing Concentration Ratio (CR)
  • 4.2.1 Neurogenetic Testing Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Neurogenetic Testing in 2021
  • 4.2.3 Global Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Neurogenetic Testing Headquarters, Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Neurogenetic Testing Headquarters and Area Served
  • 4.3.2 Global Neurogenetic Testing Companies Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Neurogenetic Testing Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Neurogenetic Testing Market Size by Company
  • 4.5.1 Top Neurogenetic Testing Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Neurogenetic Testing Revenue by Players (2020, 2021 & 2022)

5 Global Neurogenetic Testing Market Size by Region

• 5.1 Global Neurogenetic Testing Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Neurogenetic Testing Market Size by Region (2017-2028)
  • 5.2.1 Global Neurogenetic Testing Market Size by Region: 2017-2022
  • 5.2.2 Global Neurogenetic Testing Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Neurogenetic Testing Market Size YoY Growth 2017-2028
  • 6.1.2 North America Neurogenetic Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Neurogenetic Testing Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Neurogenetic Testing Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Neurogenetic Testing Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Neurogenetic Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Neurogenetic Testing Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Neurogenetic Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Neurogenetic Testing Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Neurogenetic Testing Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 Labcorp
  • 7.1.1 Labcorp Company Details
  • 7.1.2 Labcorp Business Overview
  • 7.1.3 Labcorp Neurogenetic Testing Introduction
  • 7.1.4 Labcorp Revenue in Neurogenetic Testing Business (2017-2022)
  • 7.1.5 Labcorp Recent Development
• 7.2 Pacific Biosciences of California
  • 7.2.1 Pacific Biosciences of California Company Details
  • 7.2.2 Pacific Biosciences of California Business Overview
  • 7.2.3 Pacific Biosciences of California Neurogenetic Testing Introduction
  • 7.2.4 Pacific Biosciences of California Revenue in Neurogenetic Testing Business (2017-2022)
  • 7.2.5 Pacific Biosciences of California Recent Development
• 7.3 Victorian Clinical Genetics Services
  • 7.3.1 Victorian Clinical Genetics Services Company Details
  • 7.3.2 Victorian Clinical Genetics Services Business Overview
  • 7.3.3 Victorian Clinical Genetics Services Neurogenetic Testing Introduction
  • 7.3.4 Victorian Clinical Genetics Services Revenue in Neurogenetic Testing Business (2017-2022)
  • 7.3.5 Victorian Clinical Genetics Services Recent Development
• 7.4 MedGenome Labs
  • 7.4.1 MedGenome Labs Company Details
  • 7.4.2 MedGenome Labs Business Overview
  • 7.4.3 MedGenome Labs Neurogenetic Testing Introduction
  • 7.4.4 MedGenome Labs Revenue in Neurogenetic Testing Business (2017-2022)
  • 7.4.5 MedGenome Labs Recent Development
• 7.5 Blueprint Genetics
  • 7.5.1 Blueprint Genetics Company Details
  • 7.5.2 Blueprint Genetics Business Overview
  • 7.5.3 Blueprint Genetics Neurogenetic Testing Introduction
  • 7.5.4 Blueprint Genetics Revenue in Neurogenetic Testing Business (2017-2022)
  • 7.5.5 Blueprint Genetics Recent Development
• 7.6 GeneDx
  • 7.6.1 GeneDx Company Details
  • 7.6.2 GeneDx Business Overview
  • 7.6.3 GeneDx Neurogenetic Testing Introduction
  • 7.6.4 GeneDx Revenue in Neurogenetic Testing Business (2017-2022)
  • 7.6.5 GeneDx Recent Development
• 7.7 Mayo Clinic
  • 7.7.1 Mayo Clinic Company Details
  • 7.7.2 Mayo Clinic Business Overview
  • 7.7.3 Mayo Clinic Neurogenetic Testing Introduction
  • 7.7.4 Mayo Clinic Revenue in Neurogenetic Testing Business (2017-2022)
  • 7.7.5 Mayo Clinic Recent Development
• 7.8 Neurogene
  • 7.8.1 Neurogene Company Details
  • 7.8.2 Neurogene Business Overview
  • 7.8.3 Neurogene Neurogenetic Testing Introduction
  • 7.8.4 Neurogene Revenue in Neurogenetic Testing Business (2017-2022)
  • 7.8.5 Neurogene Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details